Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Oropharyngeal pain, Oxygen saturation, Pyrexia, Weight
Clinical narrative: large, swollen, painful lymph nodes in both breasts; large, swollen, painful lymph nodes in both breasts; fever 99- 101 on and off; Lip swelling; sore throat; Fatigue; dizzy; This is a spontaneous report from a contactable consumer. A 32-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EW0164), dose 1 intramuscular, administered in Arm Left on 27Apr2021 10:59 as dose 1, single for covid-19 immunisation (at the age of 32-year-old). Medical history included possible autoimmune issue, heart block, heart pvcs, previous ovarian tumors removed, Allergies to sulfa, penicillin, seasonal allergies, strawberries, arugala, dairy, meat products, spices, Penicillins Allergy (Mild, Unverified 29Sep2020 10:17) Hives, Strawberry Allergy (Mild, Unverified 29Sep2020 10:17) Welts, Silver Allergy (Unknown, Unverified 29Sep2020 10:17) Unknown, Sulfa (Sulfonamide Antibiotics) Allergy (Unknown, Unverified 29Sep2020 10:17) Unknown, Raynauds phenomenon (Acute), Vitamin D deficiency (Acute), PTSD (posttraumatic stress disorder), Mobitz (type) I (Wenckebach's) atrioventricular block, Palpitations, Elevated blood pressure reading, Disordered eating, Chronic posttraumatic stress disorder (PTSD), GERD (gastroesophageal reflux disease), Acne, Asthma (Chronic), Anxiety (Chronic), Surgical History (Reviewed 05May2021 at 16:33 S/P removal of ovarian cyst. Former smoker quit date/quit comments: 2014 tobacco type: cigarettes packs per day: 0.25 from an unknown date and unknown if ongoing, family history of hypertension, depres-sion, diabetes mellitus (Father and Mother). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications includ-ed fexofenadine hydrochloride (ALLEGRA) taken for hypersensitivity from an unspecified start date and ongoing; fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) taken for hypersensitivity from an unspecified start date and ongoing; fish oil (FISH OIL) taken for supplementation therapy from an unspecified start date and ongoing; vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]), montelukast sodium (SINGULAIR) taken for hypersensitivity from an unspecified start date and ongo-ing; glucosamine (GLUCOSAMINE) taken for supplementation therapy, collagen (COLLAGEN) taken for supplementation therapy, vitamin b nos (VITAMIN B NOS) taken for supplementation therapy; albuterol sulfate (ALBUTEROL SULFATE) taken for an unspecified indication, ascorbic acid (ASCORBIC ACID) taken for an unspecified indication, cholecalciferol (CHOLECALCIFEROL) taken for an unspecified indica-tion, cyanocobalamin (CYANOCOBALAMIN) taken for an unspecified indication, diazepam (DIAZEPAM) taken for an unspecified indication, epinephrine (EPINEPHRINE) taken for an unspecified indication, fexofenadine (FEXOFENADINE) taken for an unspecified indication, metoprolol tartrate (METOPROLOL TARTRATE) taken for an unspecified indication, omeprazole (OMEPRAZOLE) taken for an unspecified indication, clindamycin;tretinoin (CLINDAMYCIN;TRETINOIN) taken for an unspecified indication from an unspecified start date and ongoing. Pediatric multivitamin 1 TAB.CHEW PO from an unspecified start date and ongoing. On 18May2021 11:00 patient experienced large, swollen, painful lymph nodes in both breasts for 5 weeks plus fever 99- 101 on and off for 3 weeks after the first shot and currently with the second shot (it's been over 2 weeks since my second shot) stomach cramping and pain nausea dizzy spells. HCP stated that we discussed her symptoms in great detail. At this time, her symptoms, aside from the breast tenderness are all improving. Patient and I both reviewed information online, I specifically looked on the CDC website. According to the CDC, 86 percent of anaphylactic reac-tions from the Pfizer Covid vaccine occur within the first 30 minutes after administration. I advised patient that the incidence of anaphylaxis is extremely low. Ultimately, I advised patient that she can receive her second Covid vaccination on 18May but would advise she stay at the vaccination site for 30 minutes to be observed following administration. I also advised she continue her allergy medication and consider taking Pepcid if she develops any side effects and she take her EpiPen with her to the vaccination site. If she needs to use the Epi Pen, she should go immediately to the ER to be observed. She states she does live with family, so she will be with other people after she receives a vaccine. End of the visit, patient seemed comfortable with our discussion and my recommendation. She absolutely wants to receive her second vaccine and plans to move forward with it. Patient presents for a video visit to discuss side effects from her first COVID Pfizer vaccine on 27Apr2021. The day she received her vaccine, patient reports feeling very out of it, fatigued, and dizzy. The symptoms continued into the next day. The third day after receiving her vaccine, she developed ransient swelling on the right lower side of her lip a temperature of 99.9, and a sore throat. Denies shortness of breath or difficulty swallowing, but states her throat felt weird. Denies tongue swelling.On the 6th day after vaccination, she developed swollen lymph nodes in her neck and swollen breasts which continue. Her breasts feel sore like they do prior to menses. The patient underwent lab tests and procedures which included blood pressure measurement: 120/70 mmhg on 03Jul2021 Blood Pressure: 120/70 Blood Pressure Location: Lt brachial Blood Pressure Position: sitting, body height: 5 ft 5 in on 03Jul2021 Height: 5 ft 5 in, body mass index: 23.2 on 03Jul2021 Body Mass Index BMI: 23.2, body temperature: 99 on an unspecified date, fever 99- 101, body temperature: 101 on fever 99- 101, body temperature: 96.9 fahrenheit on 03Jul2021 Temperature: 96.9 F L Temperature Source: Temporal Artery Scan, heart rate: 118 on 03Jul2021 Pulse Rate: 118 H Pulse Source: Monitor, laboratory test: normal on an unspecified date, oxygen saturation: 98 percent on 03Jul2021 02 Sat b Pulse Oximeter (percent): 98 Oxygen Deliver Method: room air, weight: 139 1b 6 oz on 03Jul2021 Weight: 139 1b 6 oz. The event required the initiation of new medication/other treatment/procedure. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Unknown if patient received treatment. The outcome of the events lip swelling, sore throat, fatigue, dizzy was recovered and Outcome for other events was not recovered.  Follow-up attempts are completed. No further information is expected.